Pictet Asset Management (Switzerland)’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$53.7M Sell
99,230
-8,795
-8% -$4.81M 0.06% 279
2023
Q1
$58.1M Buy
108,025
+6,846
+7% +$3.49M 0.07% 263
2022
Q4
$51.6M Buy
101,179
+673
+0.7% +$328K 0.07% 266
2022
Q3
$43.4M Buy
100,506
+3,054
+3% +$1.47M 0.06% 288
2022
Q2
$45.7M Buy
97,452
+4,171
+4% +$2.03M 0.06% 293
2022
Q1
$47.3M Buy
93,281
+4,846
+5% +$2.32M 0.05% 322
2021
Q4
$46.8M Sell
88,435
-8,919
-9% -$4.28M 0.05% 349
2021
Q3
$45.3M Buy
+97,354
New +$45.9M 0.05% 353

Other funds holding CHE

Pictet Asset Management (Switzerland)'s CHE Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) reduced its Chemed (CHE) stake by 8.1% in Q2 2023, selling an estimated $4.81M and leaving 99,230 shares worth $53.7M. The position accounts for 0.06% of the portfolio, ranked #279.

Pictet Asset Management (Switzerland) first reported a position in CHE in Q3 2021 and has held it in 8 quarters since. The position peaked at $58.1M in Q1 2023. 465 funds tracked by Wall St. Rank hold CHE as of Q2 2023.

  • Pictet Asset Management (Switzerland) held 99,230 shares of Chemed worth $53.7M as of Q2 2023.
  • Pictet Asset Management (Switzerland) sold 8,795 Chemed shares in Q2 2023, an estimated $4.81M.
  • Chemed made up 0.06% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #279 holding.
  • Pictet Asset Management (Switzerland) first reported a position in Chemed in Q3 2021 and has held it in 8 quarters since.
  • Pictet Asset Management (Switzerland)'s Chemed position peaked at $58.1M in Q1 2023.
  • 465 funds tracked by Wall St. Rank held Chemed as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.